Palvella Therapeutics, Inc.
PVLA· Nasdaq
PVLAPalvella Therapeutics, Inc.
Filed Mar 23, 2016 · 10-K · 83 days after period end · 0001193125-16-514870
derived · Computed from the longer spans the company filed.
| Metric | Q4 2015dderived from reported figures | Q4 2014dderived from reported figures |
|---|---|---|
| Revenue | $2.14M | — |
| Net Income | -$2.90M | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Palvella Therapeutics, Inc. · CIK 1583648 · Engraved from SEC EDGAR
ended Dec 31, 2015 · filed Mar 23, 2016 · 83 d after period end
